| Literature DB >> 22701456 |
Marc Freichel1, Julia Almering, Volodymyr Tsvilovskyy.
Abstract
Transient receptor potential (TRP) proteins form cation channels that are regulated through strikingly diverse mechanisms including multiple cell surface receptors, changes in temperature, in pH and osmolarity, in cytosolic free Ca(2+) concentration ([Ca(2+)](i)), and by phosphoinositides which makes them polymodal sensors for fine tuning of many cellular and systemic processes in the body. The 28 TRP proteins identified in mammals are classified into six subfamilies: TRPC, TRPV, TRPM, TRPA, TRPML, and TRPP. When activated, they contribute to cell depolarization and Ca(2+) entry. In mast cells, the increase of [Ca(2+)](i) is fundamental for their biological activity, and several entry pathways for Ca(2+) and other cations were described including Ca(2+) release activated Ca(2+) (CRAC) channels. Like in other non-excitable cells, TRP channels could directly contribute to Ca(2+) influx via the plasma membrane as constituents of Ca(2+) conducting channel complexes or indirectly by shifting the membrane potential and regulation of the driving force for Ca(2+) entry through independent Ca(2+) entry channels. Here, we summarize the current knowledge about the expression of individual Trp genes with the majority of the 28 members being yet identified in different mast cell models, and we highlight mechanisms how they can regulate mast cell functions. Since specific agonists or blockers are still lacking for most members of the TRP family, studies to unravel their function and activation mode still rely on experiments using genetic approaches and transgenic animals. RNAi approaches suggest a functional role for TRPC1, TRPC5, and TRPM7 in mast cell derived cell lines or primary mast cells, and studies using Trp gene knock-out mice reveal a critical role for TRPM4 in mast cell activation and for mast cell mediated cutaneous anaphylaxis, whereas a direct role of cold- and menthol-activated TRPM8 channels seems to be unlikely for the development of cold urticaria at least in mice.Entities:
Keywords: Ca2+ signaling; TRP proteins; cation channels; mast cell activation
Year: 2012 PMID: 22701456 PMCID: PMC3372879 DOI: 10.3389/fimmu.2012.00150
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Properties of channels formed by mammalian TRP proteins.
| Subtype | Selectivity PCa2+/PNa+ | Activation/modulation of activity | Consequences of TRP-deletion in mice |
|---|---|---|---|
| TRPC1 | ∼1 | PLC activation, store depletion, conformational coupling, mechanical stretch | Elevated body weight, impaired salivary gland fluid secretion |
| TRPC2 | ∼1–3 | PLC activation, diacylglycerol (DAG) | Abnormal sexual and mating behavior |
| TRPC3 | ∼1.5 | PLC activation, store depletion, conformational coupling, DAG, exocytosis | Defects in motor coordination and walking behavior |
| TRPC4 | ∼1–8 | PLC activation, store depletion (?), PIP2 breakdown, exocytosis | Impaired vascular function, altered 5-HT-mediated GABA release, defects in intestinal motility |
| TRPC5 | ∼2–9 | PLC activation, store depletion (?), sphingosine-1-phosphate, exocytosis | Decreased anxiety-like behavior |
| TRPC6 | ∼5 | PLC activation, conformational coupling, DAG, PIP3 | Grossly normal, increased artery contractility, impaired light response in intrinsically photosensitive retinal ganglion cells in TRPC6/TRPC7 compound KO mice |
| TRPC7 | ∼1–5 | PLC activation, store depletion, DAG | Impaired light response in intrinsically photosensitive retinal ganglion cells in TRPC6/TRPC7 compound KO mice |
| TRPV1 | ∼4–10 | Heat (43°C), vanilloids, proinflammatory cytokines, protons, PIP2 | Reduced inflammatory hyperalgesia, impaired bladder function |
| TRPV2 | ∼1–3 | Heat (52°C), osmotic cell swelling, exocytosis | Accelerated mortality in bacterial infection |
| TRPV3 | ∼1–10 | Warm (33–39°C); PUFAs; menthol; compounds from oregano, cloves, and thymes | Impaired thermosensation, skin barrier effects, curved whiskers, and hair |
| TRPV4 | ∼6 | Warm (27–34°C), osmotic cell swelling, 5′ 6′-EET, anandamide, 4αPDD, exocytosis | Altered body osmolarity; increased bone mass; impaired bladder function; reduced inflammatory hyperalgesia |
| TRPV5 | >100 | Constitutively active1, exocytosis (?) | Impaired renal Ca2+ reabsorption; decreased bone thickness |
| TRPV6 | >100 | Constitutively active1, store depletion (?), exocytosis (?) | Impaired epididymal Ca2+ absorption, male hypofertility, impaired Ca2+ absorption |
| TRPM1 | <1 | Translocation (?) | Impaired ON bipolar cell function and vision |
| TRPM2 | ∼0, 3–2 | ADP-ribose, cADP-ribose, pyrimidine nucleotides, arachidonic acid, NAD, H2O2, Ca2+ | Impaired neutrophil infiltration in inflammation, increased ROS production in phagocytes |
| TRPM3 | ∼1–102 | constitutively active1, osmotic cell swelling, store depletion (?), d-erythro-sphingosine (?), pregnenolone sulfate | Impaired noxious heat perception |
| TRPM4 | Monovalent selective | Ca2+, voltage modulated, PIP2 | Increased release of inflammatory mediators from mast cell and cutaneous anaphylaxis; impaired dendritic cell migration; reduced secondary hemorrhage and lesions after spinal cord injury, hypertension associated with increased catecholamine release from chromaffin cells |
| TRPM5 | Monovalent selective | Taste receptor activation (T1R, T2R), Ca2+, voltage modulated, PIP2, heat (15–35°C) | Impaired sweet, umami, and bitter taste reception; deflects in glucose-induced insulin release |
| TRPM6 | <103 | Mg2+ inhibited, translocation | Embryonic lethality, neural tube defects in development |
| TRPM7 | ∼0.2–23 | Activation mode of native channels unclear, Mg2+ inhibited, ATP, protons, phosphorylation, PIP2 | Embryonic lethality; conditional TRPM7 deletion in T cells causes abnormal thymocyte development |
| TRPM8 | ∼0.3–4 | Cool (23–28°C), menthol, icilin, pH modulated, PIP2 | Deficiencies in response to cold |
| TRPA1 | ∼0.8–5 | Cold (17°C) (?), icilin, isothiocyanates, allicin (garlic), cannabinoids, bradykinin, PLC activation, DAG, PUFAs | Reduced response to noxious cold and intestine mechanical force |
| TRPML 1 | 4 | Activation mode of native channels unclear, potentiation by low pH | Motor deficits, retinal degeneration, decreased life span |
| TRPML 2 | 4 | Activation mode of native channels unclear, potentiation by low pH | – |
| TRPML 3 | 5 | Activation mode of native channels unclear, removal, and readdition of extracellular Na+ | Varitint-waddler (Va) mice with a TRPML3 (A419P) gain of function mutation exhibit deafness, circling behavior, and pigmentation defects |
| TRPP2 | Non-selective | Translocation with TRPP1, fluid flow, mechanical gating (?) | Lethal E13; embryonic cysts and extrarenal abnormalities including left-right asymmetry of visceral organs |
| TRPP3 | ∼1–10 | Ca2+, voltage modulated | – |
| TRPP5 | non-selective | ? | – |
.
Expression of TRP transcripts and proteins in mast cell models.
| Species | Cell type | Name | Method | Reference |
|---|---|---|---|---|
| Mouse | Primary cells | BMMC | qRT-PCR | Suzuki et al. ( |
| Mouse | Primary cells | BMMC | RT-PCR | Sanchez-Miranda et al. ( |
| Rat | Cell line | RBL-2H3 | RT-PCR, WB | Ma et al. ( |
| Mouse | Primary cells | BMMC | WB | Hernandez-Hansen et al. ( |
| Human | Primary cells | skin mast cells | Affymetrix gene array | Bradding et al. ( |
| Rat | Cell line | RBL-2H3 | RT-PCR | Ma et al. ( |
| Mouse | Primary cells | BMMC | RT-PCR | Sanchez-Miranda et al. ( |
| Mouse | Primary cells | L138.8A | qRT-PCR | Sel et al. ( |
| Rat | Cell line | RBL-2H3 | RT-PCR, WB | Ma et al. ( |
| Mouse | Primary cells | BMMC | WB | Hernandez-Hansen et al. ( |
| Mouse | Primary cells | BMMC | qRT-PCR | Suzuki et al. ( |
| Mouse | Primary cells | BMMC | WB | Hernandez-Hansen et al. ( |
| Mouse | Primary cells | BMMC | qRT-PCR | Suzuki et al. ( |
| Mouse | Primary cells | BMMC | RT-PCR | Sanchez-Miranda et al. ( |
| Rat | Cell line | RBL-2H3 | RT-PCR, WB | Ma et al. ( |
| Mouse | Primary cells | BMMC | RT-PCR | Sanchez-Miranda et al. ( |
| Mouse | Primary cells | BMMC | WB | Hernandez-Hansen et al. ( |
| Mouse | Cell line | PB-3c | NB | Buess et al. ( |
| Rat | Cell line | RBL-2H3 | RT-PCR | Ma et al. ( |
| Mouse | Primary cells | BMMC | IP | Sanchez-Miranda et al. ( |
| Human | Cell line | HMC-1 | WB, RT-PCR | Zhang et al. ( |
| Human | Mast cells in bladder | IHC | Lazzeri et al. ( | |
| Rat | Cell line | RBL-2H3 | RT-PCR | Stokes et al. ( |
| Human | Skin mast cells | IHC | Stander et al. ( | |
| Human | Cell line | HMC-1 | WB, RT-PCR | Zhang et al. ( |
| Human | Cell line | HMC-1 | RT-PCR | Kim et al. ( |
| Rat | Cell line | RBL-2H3 | RT-PCR, NB, WB, ICC, qPCR | Stokes et al. ( |
| Mouse | Cell line | P815 | NB, WB | Stokes et al. ( |
| Mouse | Primary cells | BMMC | WB, (qPCR) | Stokes et al. ( |
| Rat | Cell line | RBL-2H3 | NB, WB, ICC | Stokes et al. ( |
| Mouse | Cell line | P815 | NB, WB | Stokes et al. ( |
| Human | Primary cells | HLMC | Affymetrix gene array | Bradding et al. ( |
| Human | Primary cells | Skin mast cells | Affymetrix gene array | Bradding et al. ( |
| Human | Primary cells | CBMC | Affymetrix gene array | Bradding et al. ( |
| Not reported | ||||
| Human | Cell line | HMC-1 | WB, RT-PCR | Zhang et al. ( |
| Human | Cell line | HMC-1 | RT-PCR | Kim et al. ( |
| Rat | Cell line | RBL-2H3 | ICC | Yang et al. ( |
| Rat | Cell line | RBL-2H3 | RT-PCR | Stokes et al. ( |
| Not reported | ||||
| Rat | Cell line | RBL-2H3 | RT-PCR | Stokes et al. ( |
| Not reported | ||||
| Human | Primary cells | HLMC | Affymetrix gene array | Bradding et al. ( |
| Human | Primary cells | CBMC | Affymetrix gene array | Bradding et al. ( |
| Not reported | ||||
| Mouse | Primary cells | BMMC | RT-PCR, NB, WB, ICC | Vennekens et al. ( |
| Not reported | ||||
| Not reported | ||||
| Rat | Cell line | RBL-2H3 | RT-PCR | Stokes et al. ( |
| Human | Primary cells | HLMC | RT-PCR | Wykes et al. ( |
| Human | Cell line | HMC-1 | RT-PCR | Wykes et al. ( |
| Human | Cell line | LAD-2 cells | RT-PCR | Wykes et al. ( |
| Mouse | Primary cells | BMMC | RT-PCR | Medic et al. ( |
| Rat | Cell line | RBL-2H3 | RT-PCR, ICC | Cho et al. ( |
| Rat | Cell line | RBL-2H3 | ICC, WB | Prasad et al. ( |
| Not reported | ||||
| Not reported | ||||
| Not reported | ||||
| Not reported | ||||
| Not reported | ||||
| Not reported | ||||
BMMC, bone marrow-derived mast cells; CMBC, cord blood derived mast cells; HLMC, human lung mast cells; ICC, immunocytochemistry; IHC, immunohistochemistry; IP, Immunoprecipitation; NB, Northern blot; (q)RT-PCR, (quantitative) reverse transcriptase polymerase chain reaction; WB, Western blot.